José Manasanch Dalmau

5PUBLICATIONS
13CO-AUTHORS
Clinical pharmacology and therapeuticsHuman biophysicsChiropracticCancer therapy (excl. chemotherapy and radiation therapy)Naturopathy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 09, 2022
Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study.

Antonio Alcaraz, David Castro-Díaz, Mauro Gacci

|Feb 25, 2022
Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study.

Antonio Alcaraz, Mauro Gacci, Vincenzo Ficarra

|Sep 12, 2020
Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study.

Antonio Alcaraz, Alfredo Rodríguez-Antolín, Joaquín Carballido-Rodríguez

|Nov 22, 2019
Efficacy and safety of ossein-hydroxyapatite complex versus calcium carbonate to prevent bone loss.

C Castelo-Branco, M J Cancelo Hidalgo, S Palacios

|Apr 26, 2018
Efficacy and safety of a hexanic extract of Serenoa repens (Permixon® ) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies.

Remigio Vela-Navarrete, Antonio Alcaraz, Alfredo Rodríguez-Antolín

Pageof 1

Frequent Collaborators

4 joint publications

Javier C Angulo

3 joint publications

José Medina-Polo

1 joint publications

C Castelo-Branco

1 joint publications

S Palacios